Back to search
FDAFDA · Food and drugs·Recall number D-0553-2026

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Published May 27, 2026 · Recall initiated: April 24, 2026

Summary

FDA records drug Class I recall D-0553-2026, published May 27, 2026 and initiated April 24, 2026. Recalling firm: Wisconsin Pharmacal Company; Status: Ongoing; Reported quantity: 690 tubes; Lot: Lot #: 1024088, Exp 11/30/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wisconsin Pharmacal Company
Distributor
USA Nationwide and Bahamas
Lot
Lot #: 1024088, Exp 11/30/2026
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037. recalled?

Yes. FDA published recall D-0553-2026 on May 27, 2026. Reported hazard: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

What should I do if I have this product?

Voluntary: Firm initiated · Letter